Telix Pharmaceuticals Ltd has released a press release.
2024 Full Year Results Presentation
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
In the deck
Story so far
Earlier from Telix Pharmaceuticals
- Appendix 4E and 2024 Annual Report
- Illuccix Approved in the United Kingdom
- Telix Completes Acquisition of Tx Assets, Biologics Platform
- Telix Completes Acquisition of RLS (USA) Inc
- Illuccix Receives European Approval
Later from Telix Pharmaceuticals
- Telix Announces Change in Reporting Currency to USD
- FDA accepts BLA and grants priority review for Zircaix
- Telix Completes FAP-Targeting Theranostic Acquisition
- FDA Approves New Prostate Cancer Imaging Agent Gozellix
- Telix Reports US$186M Q1 Revenue, Up 62% YOY
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals